期刊文献+

冠状动脉介入术前负荷他汀的研究进展 被引量:1

Research Progress in Statin Loading before Percutaneous Coronary Intervention
下载PDF
导出
摘要 冠状动脉介入术(PCI)是治疗冠心病的重要手段,然而PCI术后有相当部分的患者因发生心血管不良事件需再次手术或最终死亡。对其疗效、用法、使用时机、安全性等仍有不少争议。近年的研究发现,PCI术前负荷他汀治疗能有效减少心血管终点事件,改善预后。现通过对介入术前负荷他汀治疗的效果、机制、安全性等方面的文献进行综述,以期给临床研究及应用提供较系统的参考。 Percutaneous coronary intervention(PCI) is an important therapeutic regimen of coronary heart disease.However,there are a considerable proportion of patients suffering from a second operation or even death because of adverse cardiovascular events.There are still disputes over its effect,usage,time,safety and so on.In recent years,more and more clinical researches show that statin loading before PCI can effectively decrease cardiovascular endpoint events.This article summarizes the research progress in the effect,mechanism and safety of statin loading before PCI,in aiming to provide a relatively systematic reference for clinical practice.
出处 《医学综述》 2011年第5期734-737,共4页 Medical Recapitulate
关键词 冠状动脉介入术 负荷他汀 机制 效果 安全性 Percutaneous coronary intervention Statin loading Mechanism Effect Safety
  • 相关文献

参考文献29

  • 1Nissen SE,Tuzcu EM,Schoenhagen P,et al.Effect of intensive compared with moderate lipid-lowering therapy on progresion of coronary atherosclerosis:a randomized controlled trial[J].JAMA,2004,291(9):1071-1080.
  • 2Ridker PM,MacFadyen JG,Fonseca FA,et al.Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein:justification for the use of statins in prevention:an intervention trial evaluating rosuvastatin(JUPITER)[J].Circ Cardiovasc Qual Outcomes,2009,2(6):616-623.
  • 3Briguori C,Visconti G,Focaccio A,et al.Novel approaches for preventing or limiting events (Naples) Ⅱ trial:impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction[J].J Am Coll Cardiol,2009,54(23):2157-2163.
  • 4Di Sciascio G,PattiG,Pasceri V,et al.Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention:results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial[J].J Am Coll Cardiol,2009,54(6):558-565.
  • 5Patti G,Pasceri V,Colonna G,et al.Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention:results of the ARMYDA-ACS randomized trial[J].J Am Coll Cardiol,2007,49(12):1272-1278.
  • 6Yun KH,Jeong MH,Oh SK,et al.The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome[J].Int J Cardiol,2009,137(3):246-251.
  • 7Yun KH,Oh SK,Rhee SJ,et al.12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome[J].Int J Cardiol,2011,146(1):68-72.
  • 8Gibson CM,Pride YB,Hochberg CP,et al.Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome.PCI-PROVE IT:APROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy[J].J Am Coll Cardiol,2009,54(24):2290-2295.
  • 9Pasceri V,Patti G,Nusca A,et al.Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention:results from the ARMYDA (Atorvastatin for Reduction of Myocardial Damage during Angioplasty)study[J].Circulation,2004,110(6):674-678.
  • 10Merla R,Reddy NK,Wang FW.Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosis[J].J Am Coll Cardiol,2007,100(5):770-776.

二级参考文献49

  • 1栾荣华 吕树铮.ARMYDA系列研究显示,术前给予阿托伐他汀显著降低PCI围手术期不良事件危险.中国医学论坛报,2007,:33-33,18.
  • 2Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in Elderly Individuals at Risk of Vascular Disease (PROSPER): a Randomised Controlled Trial[J]. Lancet(S0140- 6736), 2002, 360(9346) : 1623- 1630.
  • 3Albert MA, Danielson E, Rifai N, et al. Effect of Statin Therapy on C-reactive Protein Levels: the Pravastatin Inflammation/CRP Evaluation (PRINCE) : a Randomized Trial and Cohort Study[J]. JAMA(S0098-7484) ,2001,286(1) :64-70.
  • 4Gotto Jr AM Jr, Farmer JA. Pleiotropic Effects of Statins: do They Matter[J]? Curr Opin Lipidol (S0957 - 9672), 2001,12 (4) :391-394.
  • 5Almuti K, Rimawi R, Spevaek D, et al. Effects of Statins Beyond Lipid Lowering: Potentialfor Clinical Benefits[J]. Int J Cardiol(S0167- 5273) ,2006,109(1) :7- 15.
  • 6Wierzbicki AS. Statins and Hypertension[J]. J Hum Hypertens( S0950 - 9240), 2006,20(8) : 554- 556.
  • 7[1]Han DK,Handenschild CC,Hong MK,et al.Evidence for apoptosis in human atherogenesis and in rat vascular injury model[J].Am J Pathol,1995,147:267-277.
  • 8[2]Isnei JM,Kearney M,Bortman S,et al.Apoptosis in human ather-osclerosis and restenosis[J].Circulation,1995,91:2703-2711.
  • 9[3]Bjorkerud S,Bjorkerud B.Apoptosis is abundant in human ather-osclerotic lesions,especially in inflammatory cells(macrophages ang T cells)and may contribute to the accumulation of gruel and plaque instability[J].Am J Pathol,1996,149:367-380.
  • 10[4]Bochaton Piallat ML,Gabbiani F,Redard M,et al.Apoptosis parti-cipates in cellularity regulation during rat aortic intimal thickening[J].Am J Pathol,1995;146:1059-1064.

共引文献63

同被引文献24

引证文献1

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部